Australian clinical AI platform Heidi has launched in the United Arab Emirates, marking its entry into the GCC and establishing its Middle East headquarters in Dubai.
The launch follows what the company described as clinician-led adoption already underway in the UAE, with roughly 80,000 consultations supported in the five months preceding the formal go-live.
Heidi’s platform automates clinical documentation and administrative tasks within the clinical workflow, with the company citing documentation burden and clinician burnout as the primary problem it addresses. The platform supports more than 120 languages, including dialectal Arabic across GCC regions, and hosts patient data in-country to meet UAE data sovereignty requirements.
The UAE launch is anchored by a strategic partnership with Nabta, described as the country’s first dedicated women’s health clinic, whose clinicians recorded 837 sessions and generated more than 1,000 notes and documents in the five months prior to launch, with monthly transcription volume rising 2.6 times between January and May 2026.
Beyond ambient documentation, Heidi offers a clinical guidance tool (Heidi Evidence), a low-connectivity version of the platform (Heidi Remote), and a patient communications tool (Heidi Comms). The company said it plans to expand across the broader GCC and Pan-Arab region from its Dubai base.
Heidi is also offering free access to its platform for small clinics and independent clinicians across all sectors in the region.
The GCC digital health AI market is forecast to grow from USD 1.5 billion in 2025 to USD 5.86 billion by 2032, according to figures cited by the company.
Discover more from HealthTechAsia
Subscribe to get the latest posts sent to your email.